Plain-English translation of NCT05610852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing two different ways to treat early prostate cancer. One approach uses robotic surgery through a single small opening to remove part of the prostate, while the other uses high-intensity focused ultrasound (HIFU)—a technique that uses focused sound waves to destroy cancer cells. Researchers want to know which treatment is more effective at stopping cancer from coming back and which one has fewer side effects on daily life.
Currently, doctors have several options for treating early prostate cancer, but it's not always clear which approach gives the best long-term results with the fewest problems like trouble with urination or sexual function. This trial will help answer those questions by directly comparing these two treatments.
You likely qualify if…
You likely don't qualify if…
You would receive one of the two treatments (randomly assigned), followed by a 3-day visit after treatment, phone calls at 1, 2, and 4 weeks, and in-person office visits at 6 weeks, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years. At these visits, your doctor will check how well the treatment worked, monitor for cancer recurrence with imaging and biopsies, and assess your quality of life including urinary function and sexual health. Long-term follow-up continues as standard care.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States